Retinal attenuates inflammatory arthritis by reciprocal regulation of IL-17-producing T cells and Foxp3+ regulatory T cells and the inhibition of osteoclastogenesis

Immunology Letters

Volumn 148, Issue 1, 2012, Pages 59-68

  Park, Mi Kyung ^a,b   Jhun, Joo Yeon ^a,b   Lee, Seon Yeong ^a,b   Oh, Hye Joa ^a,b   Park, Min Jung ^a,b   Byun, Jae Kyeong ^a,b   Yoon, Bo Young ^c   Park, Eun Mi ^a,b   Lee, Dong Gun ^a,b   Kwok, Seung Ki ^b   Park, Sung Hwan ^a,b   Kim, Ho Youn ^a,b   Cho, Mi La ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

All trans retinaldehyde (retinal); Osteoclastogenesis; Regulatory T (Treg) cells; Rheumatoid arthritis; T helper 17 (Th17)

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; INTERLEUKIN 17; RETINAL; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOREGULATION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH17 CELL;

ACID PHOSPHATASE; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; INTERLEUKIN-17; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED DBA; OSTEOCLASTS; RETINALDEHYDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84868227578     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.05.008     Document Type: Article

References (35)

1. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
2. Chen G. Immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells. Arch Immunol Ther Exp (Warsz) 2010, 58:27-36.
3. Furuzawa-Carballeda J., Vargas-Rojas M.I., Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007, 6:169-175.
4. Nakae S., Nambu A., Sudo K., Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003, 171:6173-6177.
5. Nguyen L.T., Jacobs J., Mathis D., Benoist C. Where Foxp3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 2007, 56:509-520.
6. Trapasso E., Cosco D., Celia C., Fresta M., Paolino D. Retinoids: new use by innovative drug-delivery systems. Expert Opin Drug Deliv 2009, 6:465-483.
7. Osanai M., Nishikiori N., Murata M., Chiba H., Kojima T., Sawada N. Cellular retinoic acid bioavailability determines epithelial integrity: role of retinoic acid receptor alpha agonists in colitis. Mol Pharmacol 2007, 71:250-258.
8. Miyagawa N., Homma T., Kagechika H., Shudo K., Nagai H. Effect of synthetic retinoid, TAC-101, on experimental autoimmune disease. Pharmacology 2003, 67:21-31.
9. Zunino S.J., Storms D.H., Stephensen C.B. Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice. J Nutr 2007, 137:1216-1221.
10. Racke M.K., Burnett D., Pak S.H., Albert P.S., Cannella B., Raine C.S., et al. Retinoid treatment of experimental allergic encephalomyelitis IL-4 production correlates with improved disease course. J Immunol 1995, 154:450-458.
11. Perez de Lema G., Lucio-Cazana F.J., Molina A., Luckow B., Schmid H., de Wit C., et al. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney Int 2004, 66:1018-1028.
12. Reifen R., Nur T., Ghebermeskel K., Zaiger G., Urizky R., Pines M. Vitamin A deficiency exacerbates inflammation in a rat model of colitis through activation of nuclear factor-kappaB and collagen formation. J Nutr 2002, 132:2743-2747.
13. Schambach F., Schupp M., Lazar M.A., Reiner S.L. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 2007, 37:2396-2399.
14. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256-260.
15. Mills C.M., Marks R. Adverse reactions to oral retinoids. An update. Drug Saf 1993, 9:280-290.
16. Collins M.D., Mao G.E. Teratology of retinoids. Annu Rev Pharmacol Toxicol 1999, 39:399-430.
17. Elder J.T., Kaplan A., Cromie M.A., Kang S., Voorhees J.J. Retinoid induction of CRABP II mRNA in human dermal fibroblasts: use as a retinoid bioassay. J Invest Dermatol 1996, 106:517-521.
18. Mark M., Ghyselinck N.B., Chambon P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 2006, 46:451-480.
19. Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 2000, 267:4315-4324.
20. Nozaki Y., Yamagata T., Sugiyama M., Ikoma S., Kinoshita K., Funauchi M. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin Immunol 2006, 119:272-279.
21. Kuwabara K., Shudo K., Hori Y. Novel synthetic retinoic acid inhibits rat collagen arthritis and differentially affects serum immunoglobulin subclass levels. FEBS Lett 1996, 378:153-156.
22. Camps M., Ruckle T., Ji H., Ardissone V., Rintelen F., Shaw J., et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 2005, 11:936-943.
23. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
24. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
25. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003, 198:1951-1957.
26. Collins C.B., Aherne C.M., Kominsky D., McNamee E.N., Lebsack M.D., Eltzschig H., et al. Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. Gastroenterology 2011, 141:1821-1831.
27. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
28. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000, 101:455-458.
29. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007, 37:3021-3029.
30. Seki M., Oomizu S., Sakata K.M., Sakata A., Arikawa T., Watanabe K., et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 2008, 127:78-88.
31. Zhao J., Li R., He J., Shi J., Long L., Li Z. Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells. Rheumatol Int 2008, 29:9-16.
32. Park M.K., Park J.S., Cho M.L., Oh H.J., Heo Y.J., Woo Y.J., et al. Grape seed proanthocyanidin extract (GSPE) differentially regulates Foxp3(+) regulatory and IL-17(+) pathogenic T cell in autoimmune arthritis. Immunol Lett 2011, 135:50-58.
33. Ichiyama K., Yoshida H., Wakabayashi Y., Chinen T., Saeki K., Nakaya M., et al. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. J Biol Chem 2008, 283:17003-17008.
34. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
35. Hu L., Lind T., Sundqvist A., Jacobson A., Melhus H. Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK. PLoS ONE 2010, 5:e13305.